These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39349439)

  • 1. KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer.
    Zhou K; He Y; Lin X; Zhou H; Xu X; Xu J
    Cell Death Discov; 2024 Sep; 10(1):419. PubMed ID: 39349439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
    Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
    Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.
    Pawar S; Donthamsetty S; Pannu V; Rida P; Ogden A; Bowen N; Osan R; Cantuaria G; Aneja R
    J Ovarian Res; 2014; 7():53. PubMed ID: 25028599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
    Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
    Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
    Mittal K; Choi DH; Klimov S; Pawar S; Kaur R; Mitra AK; Gupta MV; Sams R; Cantuaria G; Rida PCG; Aneja R
    J Ovarian Res; 2016 Mar; 9():17. PubMed ID: 26992853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
    Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
    J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
    Li J; Diao H; Guan X; Tian X
    Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational benchmarking of putative KIFC1 inhibitors.
    Sharma N; Setiawan D; Hamelberg D; Narayan R; Aneja R
    Med Res Rev; 2023 Mar; 43(2):293-318. PubMed ID: 36104980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM37: a critical orchestrator of centrosome function.
    Domínguez-Calvo A; Gönczy P; Holland AJ; Balestra FR
    Cell Cycle; 2021 Dec; 20(23):2443-2451. PubMed ID: 34672905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global cellular response to chemical perturbation of PLK4 activity and abnormal centrosome number.
    Tkach JM; Philip R; Sharma A; Strecker J; Durocher D; Pelletier L
    Elife; 2022 Jun; 11():. PubMed ID: 35758262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrosomal protein 120 promotes centrosome amplification and gastric cancer progression via USP54-mediated deubiquitination of PLK4.
    Zhang C; Ma X; Wei G; Zhu X; Hu P; Chen X; Wang D; Li Y; Ruan T; Zhang W; Tao K; Wu C
    iScience; 2023 Jan; 26(1):105745. PubMed ID: 36590171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.
    Sun Y; Zhang Y; Lang Z; Huang J; Zou Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation.
    Fan G; Sun L; Meng L; Hu C; Wang X; Shi Z; Hu C; Han Y; Yang Q; Cao L; Zhang X; Zhang Y; Song X; Xia S; He B; Zhang S; Wang C
    Nat Commun; 2021 Jan; 12(1):20. PubMed ID: 33397932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.
    Yeow ZY; Lambrus BG; Marlow R; Zhan KH; Durin MA; Evans LT; Scott PM; Phan T; Park E; Ruiz LA; Moralli D; Knight EG; Badder LM; Novo D; Haider S; Green CM; Tutt ANJ; Lord CJ; Chapman JR; Holland AJ
    Nature; 2020 Sep; 585(7825):447-452. PubMed ID: 32908313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIFC1: a promising chemotherapy target for cancer treatment?
    Xiao YX; Yang WX
    Oncotarget; 2016 Jul; 7(30):48656-48670. PubMed ID: 27102297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4.
    Cunha-Ferreira I; Rodrigues-Martins A; Bento I; Riparbelli M; Zhang W; Laue E; Callaini G; Glover DM; Bettencourt-Dias M
    Curr Biol; 2009 Jan; 19(1):43-9. PubMed ID: 19084407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.
    Wright N; Gong Z; Kittles R; Natarajan R; Jovanovic-Talisman T; Rida P; LaBarge M; Seewaldt V
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1.
    Wu J; Mikule K; Wang W; Su N; Petteruti P; Gharahdaghi F; Code E; Zhu X; Jacques K; Lai Z; Yang B; Lamb ML; Chuaqui C; Keen N; Chen H
    ACS Chem Biol; 2013 Oct; 8(10):2201-8. PubMed ID: 23895133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.
    Jinna N; Yuan YC; Rida P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.